An in-depth look to GENEREACH BIOTECHNOLOGY CORP operating, investing, and financing activities

4171 free cash flow for Q3 24 is -10.07 M TWD. For 2023, 4171 free cash flow was -57.96 M TWD and operating cash flow was -34.42 M TWD.